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Obesity is a serious health problem worldwide associated with an increased risk of life-
threatening diseases. A fundamental prerequisite for the development of novel 
therapeutics for obesity and its associated metabolic syndromes is an understanding of the 
regulation of fat cell development. Potential regulators include microRNAs, an abundant 
class of post-transcriptional regulators. In this study, we investigate the role of 
microRNAs in fat cell development and obesity with genome-wide expression profiling, 
characterization of specific microRNAs by gain-of-function approach and mechanistic 
study guided by computational analysis. Our results underlie the importance of 
microRNAs in adipose biology and have important therapeutic implications in the 
treatment of obesity.  
 vi
SUMMARY 
MicroRNAs (miRNAs) are important post-transcriptional regulators and affect diverse 
biological processes and many diseases. In this study, we aim to investigate the 
regulation and involvement of miRNAs in fat cell development and obesity. Using 
miRNA microarrays, we profiled miRNA expression during adipogenesis of the 
preadipocyte 3T3-L1 cells. Similar miRNAs were differentially regulated during in vitro 
and in vivo adipogenesis. We also profiled miRNA expression in purified mature 
adipocytes from leptin deficient ob/ob and diet-induced obese mice. Importantly, 
miRNAs that were induced during adipogenesis were downregulated in adipocytes from 
both types of obese mice, and vice versa. These changes are likely associated with the 
chronic inflammatory environment as they were mimicked by TNFα treatment of 
differentiated adipocytes. Ectopic expression of two adipocyte-enriched miRNAs, miR-
103 or miR-143, in preadipocytes accelerated adipogenesis, as measured both by the 
upregulation of many adipogenesis markers and by an increase in triglyceride 
accumulation at an early stage of adipogenesis. Our results provide the first experimental 
evidence for miR-103 function in adipose biology. The remarkable inverse regulatory 
pattern for many miRNAs during adipogenesis and obesity has important implications for 
understanding adipose tissue dysfunction in obese mice and humans and the link between 
chronic inflammation and obesity with insulin resistance.  
To decipher the role of miRNAs in brown fat cell development, we profiled the genome-
wide miRNA expression patterns of white fat, brown fat, and skeletal muscle. 
Interestingly, many “myogenic” miRNAs were abundant in brown fat but absent in white 
fat, which is consistent with the current notion that during lineage specification the brown 
 vii
adipocyte precursor is closer to the muscle precursor than the white adipocyte precursor. 
We identified several miRNAs that were preferentially expressed in only one of the three 
tissue types. Strikingly, ectopic expression of miR-193, a brown fat-enriched miRNA, in 
myogenic C2C12 cells inhibited myotube maturation, as evidenced by absence of key 
muscle morphological changes and also reduced expression of key myogenic proteins. 
Mechanistically, this miRNA exerts effect through direct downregulation of pro-
myogenic target genes. Taken together, our results underlie the importance of tissue 
enriched miRNAs in regulating lineage specification between brown fat and muscle. 
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Chapter 1. Introduction 
1.1 Obesity 
Obesity is a serious health problem worldwide associated with an increased risk of life-
threatening diseases such as type 2 diabetes, atherosclerosis, and certain types of cancer 
(Kopelman, 2000). The development of obesity depends on the coordinated interplay of 
adipocyte hypertrophy (increased fat cell size), adipocyte hyperplasia (increased fat cell 
number), and angiogenesis (Spiegelman and Flier, 1996). Both adipocyte hypertrophy 
and hyperplasia occur during normal growth phases and the development of obesity. A 
fundamental prerequisite for the development of novel therapeutics for obesity and its 
associated metabolic syndromes is an understanding of the regulation of fat cell 
development. 
 
There are many animal models for obesity study. One widely used model is leptin 
deficient ob/ob mice. Leptin is an adipose secreted hormone that plays a key role in 
regulating appetite and energy expenditure (Friedman, 2002; Friedman and Halaas, 1998). 
Leptin deficient obese mice are larger in size after 4 weeks of age, characterized by an 
increase in both number and size of adipocytes. In addition to obesity, they exhibit 
hyperglycemia, glucose intolerance, and insulin resistance, all of which resemble human 
pathophysiology in the context of obesity-linked type 2 diabetes. Another more 
physiologically relevant model is diet induced obese (DIO) mice. After being fed with a 
high fat diet, typically for 8 to 12 weeks, these mice become obese, mildly to moderately 
hyperglycemic, and develop impaired glucose tolerance. 
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1.2 Adipocyte function  
Adipose tissue is not only a storage depot of triglycerides, but also an endocrine organ 
and an important regulator of whole-body energy homeostasis (Figure 1-1) (Rajala and 
Scherer, 2003; Rosen and Spiegelman, 2006; Schaffler et al., 2006). Adipocyte-specific 
proteins induced during differentiation, such as adiponectin, resistin, and leptin regulate 
many aspects of lipid and glucose metabolism in adipose tissue, muscle, and liver, and 
via actions on the brain that affect food intake (Coll et al., 2007; Friedman, 2002). 
 
 
Figure 1-1. Adipose tissue is involved in many physiological and metabolic processes 
and contributes to obesity related disorders. (Adapted from Morrison and Farmer, 2000) 
 
1.3 Adipocyte differentiation 
Adipocytes are derived from multipotent mesenchymal precursor cells that commit to 
preadipocytes and then either remain quiescent or proceed to become differentiated 
adipocytes (Ailhaud et al., 1992). Many molecular markers have been associated with 
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different stages of adipocyte differentiation, also known as adipogenesis (Figure 1-2).  In 
recent years, significant advances have been made in delineating the key transcription 
factors of adipogenesis, as well as extracellular effectors and intracellular signaling 
pathways that regulate fat cell formation based on the study of several cell types that can 
be differentiated into adipocytes (Feve, 2005; Rosen and MacDougald, 2006; Rosen and 
Spiegelman, 2000; Rosen et al., 2000). 
 
1.3.1 Regulation of adipocyte differentiation 
Many signaling pathways have an effect on adipogenesis (Gesta et al., 2007; Rosen and 
MacDougald, 2006). For example, insulin and bone morphogenetic protein-2 (BMP2) 
promotes adipogenesis while Wnt-family proteins and TGFβ repress adipogenesis. It is 
important to note that the effects of some pathway may vary, depending on factor 
concentration and/or the presence of other hormones. Subsequently, various signal 
transduction pathways converge on a tightly controlled cascade of transcriptional events, 
including the coordination between transcriptional factors and co-factors, to promote or 
repress adipogenesis (Figure 1-3). PPARγ and C/EBP members form the core of the 
transcriptional network controlling adipogenesis. PPARγ, the ‘master regulator’, is both 
necessary and sufficient for adipogenesis. A cascade of C/EBP family members 
sequentially participates in regulation of adipogenesis. Early expression of C/EBPβ and 
C/EBPδ leads to the induction of C/EBPα and PPARγ, which results in a feed-forward 
effect to promote adipogenesis.   
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Figure 1-2. Cellular development of adipogenesis and markers for different stages. 
(Modified from Schaffler et al., 2006) 
 
 
Figure 1-3. A complex transcriptional cascade regulates adipogenesis. Black lines 
indicate effects on gene expression, whereas blue lines represent effects on protein 
activity. (Adapted from Rosen and Spiegelman 2006) 
 
 
Figure 1-4. Progression of 3T3-L1 differentiation. 
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1.3.2 Models for adipocyte differentiation 
Adipocyte differentiation has been extensively studied in vitro in 3T3-L1 and 3T3-F442A 
cell lines (Rosen and Spiegelman, 2000). The first and best characterized model of 
adipogenesis is the 3T3-L1 cell line, a substrain of the Swiss 3T3 mouse cell line (Green 
and Meuth, 1974). When treated with a combination of dexamethasone (Dex), 
isobutylmethylxanthine (IBMX/MIX) and insulin, post-confluent 3T3-L1 cells undergo 
clonal expansion, growth arrest and terminal differentiation (Figure 1-4). Differentiated 
adipocytes accumulate lipid droplets and express genes associated with lipid metabolism 
(FABP4), glucose homeostasis (GLUT4), and endocrine functions (adiponectin).  
 
1.4 Adipose tissue in obesity 
Adipose tissue undergoes a dramatic expansion in obesity, which eventually results in 
adipose tissue dysfunction. As adipose tissue expands, macrophage infiltration in adipose 
tissue occurs (Figure 1-5) (Wellen and Hotamisligil, 2003). Chronic inflammation and 
hypoxia are two principal features of obese adipose tissue in animals and humans 
(Trayhurn et al., 2008; Wellen and Hotamisligil, 2003). Inflammatory cytokines 
including TNF-α are largely responsible for suppressing many adipocyte-specific genes 
including PPARγ and adiponectin and reactivating expression of many cell cycle genes, 





Figure 1-5. Obese adipose tissue.  Obese adipose tissue is characterized by inflammation 
and progressive infiltration by macrophages as obesity develops. (Adapted from Wellen 
and Hotamisligil, 2003) 
 
1.5 Adipose tissue lineages 
Adipose tissue consists of white adipose tissue (WAT) and brown adipose tissue (BAT). 
White adipose tissue can be further subdivided into subcutaneous fat and visceral fat, 
which is most closely related to insulin resistance (Gesta et al., 2007). While WAT stores 
excess energy, BAT is very active in energy expenditure and has an anti-obesity function 
(Gesta et al., 2007; Seale et al., 2009). This property relies on the expression of a BAT 
specific protein, UCP1, which is a proton transporter located in the inner mitochondrial 
membrane and allows dissipation of the proton electrochemical gradient in the form of 
heat instead of ATP (Cannon and Nedergaard, 2004).  
 
While BAT persists through life in rodent, it has traditionally been considered 
insignificant in adult human. In human fetuses and newborns, BAT is found in axillary, 
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cervical, perirenal, and periadrenal regions, but decreases shortly after birth (Gesta et al., 
2007). However, using morphological studies and positron-emission tomography 
scanning studies, three independent groups have recently provided conclusive evidence 
for the existence of active BAT in adults (Cypess et al., 2009; van Marken Lichtenbelt et 
al., 2009; Virtanen et al., 2009).  Importantly, the presence of BAT negatively correlates 
with both BMI and percentage of body fat, whereas it positively correlates with resting 
metabolic rate, implicating a role of BAT in preventing obesity in adult human.  
 
White and brown adipose tissue have long been assumed to share a common 
developmental origin because they both undergo a similar differentiation program and 
express common enzymes for lipid metabolism (Gesta et al., 2007; Rosen and 
Spiegelman, 2000). However, emerging evidences favor the model that brown adipocyte 
precursor is closer to muscle precursor than white adipocyte precursor during lineage 
specification. Figure 1-6 shows the current model of the origins of fat cells. A lineage 
tracing experiment using the UCP1 promoter has demonstrated that white adipocytes are 
distinct from brown adipocytes during normal development (Moulin et al., 2001). 
Another fate mapping experiment has shown that BAT, dermis and some skeletal 
muscles are derived from a precursor expressing Engrailed 1 (En1) (Atit et al., 2006). 
Most recently, only BAT and skeletal muscle but not WAT are shown to be derived from 
precursors expressing myogenic factor 5 (Myf5) (Seale et al., 2008). In addition, brown 
preadipocytes have been reported to possess a “myogenic” transcriptional signature 
(Timmons et al., 2007). However, little is known about the regulation of lineage 
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specification between BAT and muscle as well as the molecular mechanisms underlying 
contrasting metabolic properties between WAT and BAT. 
 
 
Figure 1-6. Current model of the origins of fat cells. 
 
1.6 Biogenesis and general function of microRNAs 
microRNAs (miRNAs) constitute an abundant and evolutionarily conserved class of post-
transcriptional regulators of gene expression (Ambros, 2004; Bartel, 2004, 2009). 
miRNAs are small endogenous noncoding RNAs that base pair to sites within target 
mRNAs, triggering either a block in translation or mRNA degradation or both (Baek et 
al., 2008; Selbach et al., 2008). The expression of miRNAs is often tissue-specific or 
developmental-specific (Ambros, 2004; Bartel, 2004). The post-transcriptional programs 
controlled by miRNAs affect diverse biological processes, including development, cell 
differentiation, apoptosis, immune responses, metabolism and many diseases including 
various cancers, cardiovascular disease, viral infection and neurodegenerative diseases 
(Alvarez-Garcia and Miska, 2005; Callis and Wang, 2008; Garzon et al., 2006; Ghosh et 
al., 2009; Krutzfeldt and Stoffel, 2006; Lodish et al., 2008; Nelson et al., 2008; 
Pasquinelli and Ruvkun, 2002; Stefani and Slack, 2008). As example, signature miRNA 
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expression patterns differentiate many types of related cancers better than more classical 
analyses of mRNA profiles or protein markers, and allow better prognosis of disease 
progression (Lu et al., 2005).  
 
Figure 1-7. miRNA biogenesis and mechanisms of action. 
As outlined in Figure 1-7, miRNAs are transcribed by polymerase II or polymerase III to 
primary transcripts (pri-miRNAs) in the nucleus. Endonuclease Drosha and its cofactor 
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DGCR8 process pri-miRNA by cutting it at the bottom of its stem loop to ~70-nucleotide 
precursors (pre-miRNAs). Upon export to the cytoplasm by exportin 5 and Ran-GTP, 
Dicer generates a ~22 nucleotide miRNA duplex. One strand (mature miRNA) is then 
preferentially retained in the RNA-induced silencing complex (RISC) and base pairs with 
specific sequences in their target mRNAs. Depending on the level of complementarity, 
silencing of the transcript can occur via Argonaut-dependent mRNA cleavage or 
translational repression or both. The translationally repressed mRNA is either stored in P-
bodies or enters the mRNA decay pathway for destruction (Chekulaeva and Filipowicz, 
2009). 
 
miRNA targeting is primarily through seed-matched sites located within favorable 
predicted contexts in 3' untranslated regions (UTRs). Both computational and 
experimental studies show that each miRNA likely targets ~400 mRNAs and that almost 
half of the mRNAs in mammalian cells are targeted by one or more miRNAs (Bartel, 
2009). As a group, miRNAs may directly regulate expression of over 30% of human and 
mouse genes and more than 60% of human protein-coding genes have been under 
selective pressure to maintain pairing to miRNAs (Bartel, 2009; Friedman et al., 2009). 
Furthermore, miRNAs are attractive candidates to be involved in complex diseases such 
as obesity because the simultaneous coordination of a large number of target genes, 
potentially accomplished by a single miRNA, may be key to defining specific pathogenic 
cell states.  
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1.7 microRNAs in adipogenesis 
Although miRNA expression profiles and functions have been extensively investigated in 
the hematopoietic and neuronal systems (Gao, 2008; Kluiver et al., 2006), little is known 
about the role of miRNAs in metabolic tissues, particularly adipose tissue (Krutzfeldt and 
Stoffel, 2006). More recently, several intriguing studies have uncovered critical roles of 
miRNAs in adipogenesis. 
 
1.7.1 microRNA regulation during adipogenesis 
Attempts to catalogue miRNA expression in adipose tissue and during adipogenesis have 
been carried out using different profiling platforms. Using a miRNA cloning strategy, Gu 
et al cloned 45 known and 2 novel miRNAs from bovine adipose tissue (Gu et al., 2007). 
More recently, Liang et al further compared the expression of 345 miRNAs in 40 normal 
human tissues by quantitative reverse transcription-polymerase chain reaction (RT-PCR) 
(Liang et al., 2007). Unlike neuronal and muscular tissues, their result did not identify 
any miRNA expressed exclusively in adipose tissue. One caveat of such tissue profiling 
studies is that one could easily get fat contamination when isolating other tissues such as 
breast. Using Northern blot analyses, Kajimoto et al profiled ~100 miRNAs in mouse 
preadipocyte 3T3-L1 cells before and after differentiation and showed that 21 miRNAs 
were either up- or down-regulated during differentiation (Kajimoto et al., 2006).  
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1.7.2 microRNA function in adipogenesis 
The first evidence for participation of individual miRNAs in adipogenesis and lipid 
metabolism came from a genetic screen in Drosophila. Xu et al (Xu et al., 2003b) found 
that deletion of miR-14 results in increased levels of triacylglycerol and diacylglycerol, 
whereas increases in miR-14 copy number have the opposite effect. Using a similar 
method, Teleman et al (Teleman et al., 2006) demonstrated that homozygous mutations 
in the miR-278 gene, which is prominently expressed in the fat body of flies, causes a 
smaller fat body and reduced ratio of total body triglycerides to total protein. This 
phenotype could be rescued by miR-278 expression. Mutant flies also exhibited 
hyperglycemia in spite of elevated insulin-like peptide levels due to insulin resistance of 
the fat body. Thus, miR-278 regulates insulin sensitivity. However, miR-14 and miR-278 
have so far been found only in insects and there are no known homologues of these 
miRNAs in mammals. 
 
More compelling evidence for the role of miRNA in adipogenesis has been obtained in 
studies of mammalian cells. To screen candidates that have regulatory roles in 
adipogenesis, Esau et al (Esau et al., 2004) transfected antisense oligonucleotides 
targeting 86 human miRNAs into primary human preadipocytes. Blocking miR-143 
effectively inhibited all five adipocyte differentiation markers by at least 40%, suggesting 
a pro-adipogenic role of miR-143.  
 
A computational study predicted that the miRNA paralogs miR-103 and miR-107 affect 
multiple mRNA targets in pathways that involve cellular acetyl-CoA and lipid 
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metabolism (Wilfred et al., 2007). Interestingly, these miRNAs are derived from introns 
of the pantothenate kinase gene family members that activate pantothenate for the 
biosynthesis of coenzyme A.  
 
Since clonal expansion is one of the key events taking place in early adipogenesis of 3T3-
L1 cells in vitro, any miRNAs affecting this process could have a profound effect on 
adipogenesis. Wang et al (Wang et al., 2008) reported that the miR-17-92 cluster, which 
promotes cell proliferation in various cancers, is upregulated 2-3 fold during the early 
clonal expansion stage of 3T3-L1 adipogenesis. Stable overexpression of these miRNAs 
moderately accelerates adipocyte differentiation in vitro after hormonal stimulation. 
Additionally, this study provided convincing evidence that Rb2/p130 is a bona fide target 
of miR-17-92 during adipogenesis. This is not totally unexpected because previous 
observations suggested a p130:p107 switch during the first 24h after hormonal induction 
of adipogenesis (Richon et al., 1997).    
 
Another miRNA related to clonal expansion is let-7, which is well known to regulate cell 
proliferation and differentiation processes in species ranging from C. elegans to human 
(Johnson et al., 2005; Reinhart et al., 2000). Expression of let-7 slightly decreased from 
day 0 to day 1 and then increased during terminal adipogenesis (Sun et al., 2009). Ectopic 
expression of let-7 by transfecting pre-let-7 oligonucleotide into 3T3-L1 cells prior to 
induction of differentiation inhibited clonal expansion as well as terminal differentiation, 
in part by targeting HMGA2 (Sun et al., 2009). Interestingly, mice lacking HMGA2 have 
marked reductions in adipose tissue (Zhou et al., 1995). However, the involvement of the 
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miR-17-92 cluster and let-7 during in vivo fat cell development awaits further 
investigation since clonal expansion is not required for primary preadipocyte 
differentiation.  
 
Among many downregulated miRNAs during adipogenesis, the miR-27 gene family has 
been functionally characterized using 3T3-L1 preadipocytes and OP9 mouse bone 
marrow mesenchymal stem cells (Lin et al., 2009). Overexpression of miR-27 by 
transfecting miR-27 precursors before adipogenic stimulation specifically inhibited 
adipocyte formation. Mechanistically, miR-27 prevents the induction of PPARγ and 
C/EBPα, the two master transcriptional regulators of adipogenesis. Interestingly, 
although PPARγ contains a putative binding site for miR-27, miR-27 does not repress the 
level of PPARγ protein in differentiating 3T3-L1 cells if miR-27 was transfected after 2 
days after adipogenic stimulation. Therefore, it is plausible that miR-27 inhibits 
adipogenesis by targeting an unknown gene that prevents the transcriptional induction of 
PPARγ.  
 
1.8 miRNAs in lineage specification 
miRNAs play important roles in development and lineage specification. For example, 
lsy-6 and miR-273 control left-right asymmetry in the ASE neurons during neural 
development of C. elegans (Chang et al., 2004; Johnston and Hobert, 2003). During 
differentiation of mESC derived neural progenitors, modulation of the relative levels of 
brain-specific miR-124a and miR-9, both brain-enriched miRNAs, alters the ratio of cells 
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of the glial versus neuronal lineages (Krichevsky et al., 2006). In addition, pancreatic 
islets specific miR-375 is required to maintain normal alpha and beta cell mass miR-375 
knock-out mice exhibit increased alpha cell numbers but decreased beta cell numbers 
(Poy et al., 2009). 
 
1.9 Aims of the present study 
miRNAs are potential regulators of adipocyte differentiation and adipose tissue 
development and they may be dysregulated in disease state. The purpose of the present 
study was to elucidate the role of miRNA in fat cell development and obesity. The 
specific aims were as follows: 
(1) To identify candidate miRNAs regulated during adipogenesis and dysregulated in 
adipocytes of obese state; 
(2) To characterize the function of candidate miRNAs in fat cell development; 
(3) To investigate the role of miRNAs in lineage determination between white fat, brown 
fat and muscle. 
 
The first two aims will be addressed in Chapter 2 and the last aim will be addressed in 






Chapter 2. MicroRNAs in adipogenesis and obesity 
2.1 Abstract 
We investigated the regulation and involvement of microRNAs in fat cell development 
and obesity. Using miRNA microarrays, we profiled the expression of more than 370 
miRNAs during adipogenesis of preadipocyte 3T3-L1 cells and adipocytes from leptin 
deficient ob/ob and diet-induced obese mice. Changes in key miRNAs were validated by 
RT-PCR. We further assessed the contribution of the chronic inflammatory environment 
in obese adipose tissue to the dysregulated miRNA expression by TNFα treatment of 
adipocytes. We functionally characterized two adipocyte-enriched miRNAs, miR-103 
and miR-143 by a gain-of-function approach. Similar miRNAs were differentially 
regulated during in vitro and in vivo adipogenesis. Importantly, miRNAs that were 
induced during adipogenesis were downregulated in adipocytes from both types of obese 
mice, and vice versa. These changes are likely associated with the chronic inflammatory 
environment as they were mimicked by TNFα treatment of differentiated adipocytes. 
Ectopic expression of miR-103 or miR-143 in preadipocytes accelerated adipogenesis, as 
measured both by the upregulation of many adipogenesis markers and by an increase in 
triglyceride accumulation at an early stage of adipogenesis. Our results provide the first 
experimental evidence for miR-103 function in adipose biology. The remarkable inverse 
regulatory pattern for many miRNAs during adipogenesis and obesity has important 
implications for understanding adipose tissue dysfunction in obese mice and humans and 




Adipose tissue is not only a storage depot of triglycerides, but is also an endocrine organ 
and an important regulator of whole body energy homeostasis (Rajala and Scherer, 2003; 
Rosen and Spiegelman, 2006; Schaffler et al., 2006). Abnormal fat accumulation in 
obesity increases risk of life-threatening diseases such as type 2 diabetes, atherosclerosis, 
and certain types of cancer (Calle and Kaaks, 2004; Kopelman, 2000). Fundamental for 
the development of novel therapeutics for obesity and its associated metabolic syndromes 
is an understanding of the regulation of adipogenesis, which is tightly controlled by a 
combination of multiple transcription factors and extracellular hormones such as insulin 
(Feve, 2005; Rosen and MacDougald, 2006; Rosen and Spiegelman, 2000).  
 
Potential regulators of adipogenesis include microRNAs (miRNAs), which encode an 
abundant class of ~22-nucleotide evolutionarily conserved RNAs that control gene 
expression at the post-transcriptional level by targeting mRNAs for degradation or 
translational repression or both (Baek et al., 2008; Bartel, 2004; Selbach et al., 2008). 
Computational and experimental analyses suggest that miRNAs may regulate expression 
of ~30% of human and mouse genes (Lewis et al., 2005). Furthermore, miRNAs are 
attractive candidates for regulating cell fate decisions and complex diseases such as 
obesity because the simultaneous coordination of a large number of target genes, 
potentially accomplished by a single miRNA, may be key to defining specific 
differentiated or pathogenic cell states. 
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Although miRNA expression profiles and functions have been extensively investigated in 
the hematopoietic system and neuronal and muscle tissues (Callis et al., 2008; Gao, 2008; 
Kluiver et al., 2006), little is known about the role of miRNAs in metabolic tissues, 
particularly adipose tissue (Krutzfeldt and Stoffel, 2006). Of particular relevance, miR-14 
and miR-278 in the fat body of flies regulate lipid metabolism (Teleman et al., 2006; Xu 
et al., 2003b); miR-122 in mouse liver controls triglyceride metabolism and cholesterol 
biosynthesis (Esau et al., 2006; Krutzfeldt et al., 2005); and experiments using antisense 
oligonucleotides transfected into cultured human preadipocytes suggested that miR-143 
is involved in adipocyte differentiation (Esau et al., 2004). Using Northern blot analyses, 
Kajimoto et al profiled about 100 miRNAs including 3 novel miRNAs in 3T3-L1 cells 
before and after differentiation (Kajimoto et al., 2006), and Gu et al cloned 45 known and 
2 novel miRNAs from bovine adipose tissue (Gu et al., 2007). Moreover, as based on 
computational analysis of miRNA target sites in their 3’ untranslated region (UTR) 
sequences, 71% (282 out of 395) of expressed sequence tags with unique 3’UTR’s 
differentially expressed during 3T3-L1 differentiation are potentially regulated by 
miRNAs (Hackl et al., 2005). 
 
However, few adipocyte miRNAs have been analyzed, in part because of the low 
sensitivity and coverage of cloning and Northern blot analyses. Except for miR-143 none 
of the candidate adipocyte-important miRNAs overlapped in the studies of Esau et al 
(Esau et al., 2004) and Kajimoto et al (Kajimoto et al., 2006). Previous studies also 
employed unfractionated primary adipose tissue, which consists of a heterogeneous 
mixture of cell types (Gomez-Ambrosi et al., 2004; Gu et al., 2007; Moraes et al., 2003; 
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Nadler et al., 2000; Soukas et al., 2000). And except for knocking down expression of 
miR-143, there have been no functional characterizations of adipocyte miRNAs. 
Additionally, there has been no systematic comparison of miRNA expression levels in 
normal and obese states, despite the fact that many adipose-important mRNAs are 
dysregulated in adipocytes from obese animals and humans (Gomez-Ambrosi et al., 2004; 
Moraes et al., 2003; Nadler et al., 2000; Soukas et al., 2000).  
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2.3 Materials and methods 
Cell culture, differentiation and chemical treatments 
3T3-L1 cells (American Type Culture Collection) were cultured and differentiated as 
described earlier (Bogan et al., 2001). For TNFα treatment, 1 nM human TNFα 
(PeproTech) was added to the growth medium on day 8 after induction of differentiation 
and incubated for 24 hours as described previously (Ruan et al., 2002).  
 
Mouse studies  
Male C57BL/6J and B6.V-Lepob/J (ob/ob) mice (Jackson Laboratory) were maintained at 
the animal facility of the Whitehead Institute for Biomedical Research. All animal 
experiments were performed with the approval of the Massachusetts Institute of 
Technology Committee on Animal Care. For ob/ob model, all mice were provided with 
normal chow diet. Epididymal fat pads were harvested from mice at 16-17 weeks of age. 
For the diet-induced obesity model, we randomized ten 6 week old male C57BL/6J 
littermates to either normal chow diet or high fat diet (55% fat, Teklad). After 3 months, 
epididymal fat pads were harvested. Fat tissues from 2-4 mice of the same group were 
pooled together as one biological sample for microarray or RT-PCR experiments. 
Primary adipocytes were obtained after collagenase/dispase digestion and enriched 
preadipocytes (CD11b-CD90-CD31-) were isolated by a negative selection on an 





miRNA microarray and data analysis  
Total RNA including miRNA was extracted using miRNeasy Mini kit according to the 
manufacturer’s protocol (Qiagen). Six µg total RNA was size fractionated and the small 
RNAs (<300nt) isolated were 3’-extended with a poly(A) tail using poly(A) polymerase 
and labeled with Cy3 or Cy5. Hybridizations were performed on a microfluidic biochip 
platform (LC sciences) as described previously (Zhu et al., 2007). Microarrays with 
miRNA content corresponding to miRbase v9.0 or v9.1 (nine probes for each miRNA on 
one chip) were used for profiling during 3T3-L1 adipogenesis and for comparison 
between wild type and ob/ob mice whereas microarrays with miRNA content 
corresponding to miRbase v10.1 (six probes for each miRNAs on one chip) were used for 
comparison between control and DIO mice. Data were analyzed by first subtracting the 
background, then normalizing the signals using a LOWESS filter. The ratio of the two 
sets of detected signals (log2 transformed, balanced) and p-values of the t-test were 
calculated for each probe; differentially regulated miRNAs were those with more than 
50% repeating probes on one chip with P < 0.01 (Student’s t test) between the Cy3 and 
Cy5 signals. Overlapping differentially regulated miRNAs between two biological 
replicates were considered as regulated miRNAs. Complete miRNA microarray data and 
detailed protocols are deposited into ArrayExpress (Accession number: E-MEXP-1789, 
E-MEXP-1930, E-MEXP-1932). miRNAs described in this paper are referred to by their 





Quantitative real time RT-PCR assay 
For miRNA RT-PCR, 10 ng RNA was reverse transcribed and individual Taqman 
primers were used for PCR according to the manufacturer’s instruction (Applied 
Biosystems). snoRNA202 was used as the internal control. For mRNA RT-PCR, 1 μg 
RNA was reverse transcribed with random primers by SuperScriptTM II Reverse 
Transcriptase (Invitrogen) and PCR amplified with gene-specific primers and SYBR 
Green PCR master mix using ABI 7900HT according to the manufacturer’s protocol 
(Applied Biosystems). 18S was used as the internal control. Data were analyzed by the 
relative quantification (ΔΔCt) method.  
 
miRNA gene cloning and ectopic expression 
Authentic miRNA stem-loop and about 220 nucleotides flanking sequences on the 5’ and 
3’ side of the mature miR-103 or miR-143 was amplified from normal mouse genomic 
DNA (Clontech) and cloned into the retroviral vector MDH.xdna as described previously 
(Chen et al., 2004). Empty vector or expression plasmid with miRNA (8 μg) was co-
transfected into 293T cells with retrovirus packaging vector pCL-Eco (4 μg) using 
FuGene 6 according to the manufacturer’s protocol (Roche). Virus supernatant was 
collected and used to infect 3T3-L1 cells with the addition of polybrene (Sigma) to a final 
concentration of 4 μg/mL. Infected cells were sorted by FACS to collect the top 30-40% 





Proliferation assay  
3T3-L1 cells expressing miRNA or empty vector alone were seeded in 96-well plates 
(Corning) at a density of 10,000 cells per well. After 3 days, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay was performed with MTT Cell 
Proliferation Assay kit according to the manufacturer’s protocol (American Type Culture 
Collection).  
 
Triglyceride assay  
On days 4 or 7 after differentiation, 3T3-L1 cells were harvested in 300 μL lysis buffer 
(50mM Tris-HCl, PH=7.4, 150mM NaCl, 1% Triton X-100) and sonicated to 
homogenize the cell suspension. Triglyceride level was measured using a serum 
triglyceride determination kit according to the manufacturer’s instructions (Sigma). 




Data are expressed as mean ± SEM unless otherwise indicated. Student's t test (unpaired, 
two-tail) was used to compare two groups and p value was calculated in Excel (Microsoft) 
or GraphPad Prism 5 (GraphPad Software). Pearson’s correlation analysis and Fisher’s 
exact test were performed in GraphPad Prism 5 (GraphPad Software). For Pearson's 
correlation analysis, miRNAs from the same genomic cluster (<50 kb) were treated as 
one entity and their expression levels were averaged. P < 0.05 was considered as 
statistically significant.  
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2.4 Results 
miRNA expression during in vitro adipogenesis of 3T3-L1 preadipocytes 
We profiled the expression of miRNAs during 3T3-L1 cell adipogenesis using miRNA 
microarrays detecting 373 mouse mature miRNAs (miRbase v9.0). Data from two 
biological replicates were consistent (data not shown). Most miRNAs fell along the 
diagonal line in the intensity scatter plot, indicating that they were not regulated during 
the 9 days of adipogenesis (Figure 2-1A).  Based on criteria described in the Materials 
and Methods section, 28 miRNAs were expressed at significantly different levels 
between undifferentiated 3T3-L1 preadipocytes (Day 0) and differentiated 3T3-L1 
adipocytes (Day 9) (Figure 2-1A, P < 0.01, Student’s t test). Expression profiles of 
miRNA isolated during 3T3-L1 differentiation indicated that major changes occurred as 
early as days 2 to 4 (data not shown). Of the miRNAs differentially expressed, the eight 
miRNAs significantly upregulated during differentiation, namely miR-422b, 148a, 107, 
103, 30c, 30a-5p, 146b, 143 and the four downregulated miRNAs, namely miR-125b, 
99b, 222, 221, were selected for validation by quantitative RT-PCR assays using samples 
derived from an independent set of experiments. The results confirmed our findings from 
the microarrays (Figure 2-1B).  
 
miRNA expression during primary fat cell development 
To further examine the expression profiles during in vivo fat cell development, enriched 
epididymal adipocytes were purified by floatation after collagenase/dispase digestion and 
dissociation; enriched preadipocytes (CD11b-CD90-CD31-) in the stromal vascular 
fraction were depleted of fibroblasts, endothelial cells, macrophages and erythrocytes. 
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Differentiation of these enriched preadipocytes showed enhanced formation and 
accumulation of lipid droplets compared with the total population of cells in the stromal 
vascular fraction (data not shown). Expression levels of the same 12 selected miRNAs 
shown in Figure 2-1B were measured by RT-PCR in RNAs from enriched preadipocytes 
and mature primary adipocytes. As shown in Figure 2-1C, 9 out of 12 miRNAs exhibited 
a similar regulation pattern compared to in vitro differentiation. Noteworthy is the fact 
that miR-143 expression increases to a larger extent in vivo compared to adipogenesis of 
3T3-L1 cells; this is one of the miRNAs we selected for overexpression in 3T3-L1 
preadipocytes (Figure 2-6). 
 
Co-expression of intronic miRNAs with “host” genes  
Some of the differentially regulated miRNAs originated from introns of known genes. 
For example, miR-422b is located in the sense orientation in the first intron of PPARγ 
coactivator 1β (PPARGC1b). miR-107, miR-103-1 and miR-103-2 reside in the sense 
orientation in intron 5 of three Pantothenate kinase (PANK) gene family members, 
PANK1, PANK3 and PANK2, respectively. All of these intronic miRNAs were co-
regulated with their respective host genes during 3T3-L1 adipogenesis (Figure 2-1D).  
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Figure 2-1. miRNA expression profiling during 3T3-L1 adipogenesis.  
(A) Intensity scatter plot showing comparison of miRNA profiles between 
undifferentiated 3T3-L1 preadipocytes (Day 0) and differentiated 3T3-L1 adipocytes 
(Day 9). The 12 miRNAs that are the focus of our detailed analyses are highlighted in red 
and indicated by a label.  
(B) Validation of miRNA array results for 12 regulated miRNAs by RT-PCR assays. 
Expressions for all miRNAs are plotted as fold change in log2 scale; positive indicates 
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enriched in Day 9 vs. Day 0. White bar: array result (n=2); Black bar: RT-PCR result 
(n=4). Data are expressed as mean ± SEM. 
(C) Comparison by RT-PCR of miRNA regulation during 3T3-L1 differentiation and 
primary fat cell development. Expressions of all miRNAs are normalized to internal 
control and plotted as fold change in log2 scale. Black bar: Day 9 vs. Day 0, same data as 
Figure 1B (n=4); White bar: mature adipocyte vs. enriched preadipocyte (n=4); Data are 
expressed as mean ± SEM. 
(D) Intronic miRNAs and their host genes are co-regulated during adipogenesis. miR-
422b is in the intron of PPARGC1b; miR-107 is in the intron of PANK1; the two copies 
of miR-103 are in the introns of PANK2 and PANK3. miRNA expression levels are 
measured by RT-PCR and normalized to internal control. Expression levels of mRNAs 
are also determined by RT-PCR and normalized to internal control. Expressions are 
shown as fold change relative to the level at Day 0. White bar: Day 0; Black bar: Day 2; 
Hatched bar: Day 4. Data are expressed as mean ± SEM (n=3). 
 
miRNA expression in adipocytes from obese mice  
To identify candidate miRNAs associated with abnormal fat accumulation, the same 
miRNA microarrays were employed to compare miRNA levels in normal adipocytes with 
those of obese mice. We first used leptin deficient ob/ob mice; at 4 weeks of age ob/ob 
mice are obese and exhibit hyperglycemia, glucose intolerance, and insulin resistance, 
phenotypes that resemble the pathophysiology of human type 2 diabetes (Tschop and 
Heiman, 2001). 71 miRNAs were expressed at significantly different levels (Figure 2-2A, 
P < 0.01, Student’s t test). Twelve regulated miRNAs, including 9 downregulated and 3 
upregulated in ob/ob mice were validated by RT-PCR assays (Figure 2-2B).  
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Figure 2-2. miRNA expression profiling in adipocytes from wild type and leptin deficient 
ob/ob mice.   
(A) Intensity scatter plot showing comparison of miRNA profiles in adipocytes from wild 
type (WT) and ob/ob mice. The 12 miRNAs that are the focus of our detailed analyses 
are highlighted in red and indicated by a label.  
(B) Validation of miRNA array results for 12 regulated miRNAs by RT-PCR assays. 
Expression of all miRNAs are normalized to internal control and plotted as fold change in 
log2 scale. White bar: array result (n=2); Black bar: RT-PCR result (n=2). Data are 
expressed as mean ± SEM. 
 
We also used diet-induced obese (DIO) mice as a model of obesity. After being fed with 
a 55% high fat diet for 3 months (from weeks 6 to 18), DIO mice became significantly 
heavier than normal and had almost twice the mass of epididymal fat compared to 
littermate controls (Figures 2-3A and 2-3B, P < 0.01, Student’s t test). Using an updated 
miRNA microarray capable of detecting 569 mouse miRNAs (miRbase v10.1) and 5 
novel miRNAs cloned from adipose tissue by Kajimoto et al (Kajimoto et al., 2006) and 
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Gu et al (Gu et al., 2007) for this comparison, 35 miRNAs were expressed at significantly 
different levels (Figure 2-3C, P < 0.01, Student’s t test). Notably, the recently 
discovered mirtron miR-1224 and one novel miRNA cloned from bovine adipose tissue 
(Novel_miR#5: 5’- GGGCCGUGCGCGGGGUCUGC -3’) were expressed above the 
mean of expression of all miRNAs. Six miRNAs including 4 upregulated and 2 
downregulated in DIO mice were selected for validation with RT-PCR assays; the results 
again agreed well with the microarray data (data not shown).  
 
To compare changes in miRNA expression between these two models of obesity, we 
focused on a set of 78 miRNAs, whose expression levels were above the mean expression 
of all miRNAs in at least one of the four samples analyzed: enriched adipocytes from 
wild-type (WT) and ob/ob mice (Figure 2-2), and adipocytes from control and DIO mice 
(Figure 2-3C). As shown in Figure 2-3D, there was a strong positive correlation 
between changes in miRNA expression levels in the two obesity models (r = 0.51, P < 
0.0001, Pearson’s correlation). This suggested that similar sets of miRNAs are up or 
down regulated in these two models of obesity, although the extent of regulation was 
usually more striking in adipocytes from ob/ob compared to DIO mice.  
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Figure 2-3. miRNA expression profiling in adipocytes from control and diet-induced 
obese (DIO) mice.   
(A) Weight of control and DIO mice (n=5). DIO mice were fed with 55% high-fat diet 
starting from week 6 to week 18. Controls were fed with normal chow diet. Data are 
expressed as mean ± SEM. ** P < 0.01. 
(B) Weight of epididymal fat pads from control and DIO mice (n=5) at week 18. ** P <  
0.01. 
(C) Intensity scatter plot showing comparison of miRNA profiles in adipocytes from 
control and DIO mice. Mirtron miR-1224, Novel_miR#5 (novel miRNA cloned from 
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bovine adipose tissue described in the text) and some miRNAs used in our detailed 
analyses are highlighted in red and indicated by a label.  
(D) Scatter plot showing the positive correlation of miRNA regulation in two disease 
models for obesity: ob/ob and DIO mice. 78 miRNAs, whose levels are above the mean 
expression of all miRNAs in at least one of the four samples: enriched adipocytes from 
wild-type, ob/ob, control, and DIO mice, are shown. Fold changes are based on array 
results and plotted in log2 scale. Some miRNAs used in our detailed analyses are 
highlighted in red and indicated by a label. Pearson’s correlation coefficient r=0.51, P <  
0.0001.  
 
Inverse correlation of miRNA expression during adipogenesis and obesity 
Importantly, we noticed that miRNAs upregulated during adipogenesis tended to be 
downregulated in the obese state, and vice versa. For example, miR-422b, 148a, 107, 103, 
30c, 30a-5p and 143 were induced during adipogenesis but were downregulated in obese 
adipocytes. Conversely, miR-222 and 221 were decreased during adipogenesis but were 
upregulated in obese adipocytes (Figures 2-1B and 2-2B). 
 
To test our observation more rigorously and on a larger scale, we focused on a set of 79 
miRNAs, whose expression levels were above the mean expression of all miRNAs in at 
least one of the four samples analyzed: undifferentiated 3T3-L1 preadipocytes (Day 0), 
differentiated 3T3-L1 adipocytes (Day 9), and adipocytes from WT and ob/ob mice. The 
regulation patterns of these 79 miRNAs are shown as a scatter plot in Figure 2-4A (r=-
0.51, P < 0.0001, Pearson’s correlation) and categorized in Figure 2-4B. Amongst the 41 
miRNAs upregulated during differentiation, 31 miRNAs decreased during obesity. In 
contrast, amongst the 38 miRNAs downregulated during differentiation, 26 miRNAs 
were elevated during obesity. The inverse correlation between miRNAs implicated in 
adipogenesis and obesity was statistically significant (Figure 2-4B, P = 0.0001, Fisher’s 
exact test).  
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Figure 2-4. Inverse correlation of miRNA expression during adipogenesis and obesity.  
(A) Scatter plot showing the inverse correlation of miRNA regulation during 
adipogenesis and obesity. 79 miRNAs, whose levels are above the mean expression of all 
miRNAs in at least one of the four samples: undifferentiated 3T3-L1 preadipocytes (Day 
0), differentiated 3T3-L1 adipocytes (Day 9), and adipocytes from wild-type and ob/ob 
mice, are shown. Fold change is based on array result and plotted in log2 scale. The 12 
miRNAs that are the focus of our detailed analyses are highlighted in red and indicated 
by a label. Pearson’s correlation coefficient r = -0.51, P < 0.0001.  
(B) Fisher's exact test for 79 miRNAs shown in Figure 3(A). 41 miRNAs were 
upregulated during differentiation (Diff_Up), among which 31 miRNAs were 
downregulated during obesity (Ob_Down) while 10 miRNAs were upregulated (Ob_Up). 
38 miRNAs were downregulated during differentiation (Diff_Down), among which, 26 
miRNAs were upregulated during obesity (Ob_Up) while 12 miRNAs were 
downregulated (Ob_Down). P = 0.0001 by Fisher’s exact test.  
 
miRNA regulation by TNFα in adipocytes from obese mice 
Chronic inflammation by macrophages is a principal feature of obese adipose tissue 
(Schaffler et al., 2006; Weisberg et al., 2003; Wellen and Hotamisligil, 2003; Xu et al., 
2003a); TNFα is a major macrophage-produced cytokine involved in chronic 
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inflammation and is largely responsible for inducing insulin resistance in obese adipose 
tissue (Cawthorn and Sethi, 2008). Previously, we reported that in 3T3-L1 adipocytes 
TNFα treatment suppressed expression of many adipocytes specific genes and 
reactivated expression of preadipocyte genes, inducing insulin resistance (Ruan et al., 
2002).  Figure 2-5 shows, using quantitative RT-PCR assays, that treatment of 
differentiated 3T3-L1 adipocytes for 24 hours with TNFα reduced the expression of the 
same miRNAs, including miR-103 and miR-143 that were downregulated in adipose 
tissue from ob/ob mice. Conversely, TNFα induced the expression of 3 miRNAs, 
including miR-221 and miR-222 that were normally downregulated during adipogenesis 
and upregulated during obesity. Thus, the changes in miRNA expression we observed in 
adipocytes from both ob/ob and DIO mice likely were caused by the enhanced expression 
of TNFα seen in obese adipose tissue.  
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Figure 2-5. miRNAs differentially expressed in adipocytes from ob/ob mice compared 
with wild type mice are regulated similarly by TNFα treatment of 3T3-L1 differentiated 
adipocytes for 24 hours. miRNA levels are measured by RT-PCR, normalized to internal 
control and plotted as fold change in log2 scale. X axis, ob/ob vs. WT, same data as 
Figure 2B; Y axis, differentiated adipocyte after TNFα treatment for 24 hours vs. 
untreated control (n=4). Pearson’s correlation coefficient r = 0.90, P < 0.0001. 
 
miR-103 and miR-143 accelerate adipogenesis when expressed ectopically  
To determine whether the changes in miRNA expression we observed might affect 
adipogenesis, we focused on two miRNAs, miR-103 and miR-143, that were upregulated 
during adipogenesis and downregulated during obesity. Both miRNAs are highly 
conserved and are abundant in adipocytes. The level of mature miR-143 increased 
slightly during 3T3-L1 adipogenesis, but the rise is much more dramatic in vivo (Figures 
2-6A and 2-1C). Expression of miR-103 was induced approximately 9 fold during 
adipogenesis, with the increase occurring mainly after Day 2 (Figure 2-6A).  
 
To evaluate the effects of these miRNAs on preadipocyte growth and differentiation, we 
used a retroviral vector to stably express them in 3T3-L1 preadipocytes. GFP was used as 
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a reporter so that infected 3T3-L1 cells could be easily selected by fluorescence-activated 
cell sorting. We obtained four independent batches of miRNA overexpressing cells. GFP+ 
cells expressed 3-4 fold higher levels of mature miRNA compared to control 
preadipocytes that expressed the empty vector alone (Figure 2-6B). Thus miR-103 and 
miR-143 were ectopically expressed at physiological levels.  
 
Figure 2-6C shows that ectopic expression of miR-103 or miR-143 has little effect on 
3T3-L1 cell growth. Without adipogenic stimuli there were no evident morphological 
changes in 3T3-L1 cells ectopically expressing these miRNAs (data not shown). 
However, ectopic expression of miR-103 or miR-143 did accelerate the rate of 3T3-L1 
differentiation, as measured by triglyceride accumulation (Figure 2-6D) and by the 
upregulation of many adipocyte-important genes at early stages of adipogenesis (Figure 
2-6E). Figure 2-6D shows that cells ectopically expressing either miR-103 or miR143 
accumulated twice the normal level of triglyceride at day 4 of differentiation, but a 
normal level of triglyceride at day 7.  
 
The accelerated differentiation was accompanied by increased expression of key 
transcription factors such as PPARγ2, key cell cycle regulators such as G0/G1 switch 2 
(G0s2), and molecules associated with lipid metabolism (FABP4), glucose homeostasis 
(GLUT4), and endocrine functions (adiponectin) of adipocytes. Quantitative RT-PCR 
showed that ectopic expression of miR-103 or miR-143 caused little change in the low 
level of expression of these genes before the onset of differentiation (day 0). Importantly, 
ectopic expression of miR-103 or miR-143 did hasten the expression of these pro-
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adipogenic factors at early stages of adipogenesis (Figures 2-6E and 2-6F). At day 2, for 
example, expression of PPARγ2 was doubled by ectopic expression of either miR-103 or 
miR-143. miR-103 increased the expression level of FABP4 and adiponectin ~9 fold and 
4 fold, respectively (Figure 2-6F). Gene expression profiling by microarrays (data not 
shown) also suggested a significant enrichment of other proteins known to be important 
during adipogenesis or in lipid metabolism pathways in day 2 cells in which miR-103 or 
miR-143 was ectopically expressed compared to control cells at day 2. Notably, neither 
miR-103 nor miR-143 modulated early adipogenic markers such as LPL at day 0 (Figure 
2-6E and data not shown).  Levels of miR-103 and miR-143 are normally induced early 
in differentiation, and they likely downregulate expression of unknown mRNAs whose 
encoded protein(s) normally slow the process of adipogenesis. 
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Figure 2-6. Ectopic expression of two adipocyte-induced miRNAs, miR-103 or miR-143 
accelerates adipogenesis.  
(A) miR-103 and miR-143 are induced during 3T3-L1 adipogenesis. miRNA expression 
levels are measured by RT-PCR, normalized to internal control and plotted relative to 
their respective levels in preadipocyte (Day 0). Data are expressed as mean ± SEM (n=3).  
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(B) Expression level of miR-103 or miR-143 in infected and sorted cells compared to 
vector control. Data are expressed as mean ± SEM (n=3). 
(C) Ectopic expression of miR-103 or miR-143 has little effect on 3T3-L1 cell growth by 
MTT assay. Data are expressed as mean ± SEM (n=6). 
(D) Ectopic expression of miR-103 or miR-143 increases triglyceride accumulation at 
day 4 (D4) but not day 7 (D7). Triglycerides are normalized to total protein and plotted 
relative to the level of the control cells expressing vector alone at D7. Data are expressed 
as mean ± SEM (n=6). ** P < 0.01, * P < 0.05.  
(E) Ectopic expression of miR-103 or miR-143 hastens expression of adipogenic markers 
at early stage (Days 2 and 4) of adipogenesis. mRNA levels are measured by RT-PCR, 
normalized to internal control and plotted relative to their respective levels at day 2 (D2). 
Data are expressed as mean only (n=3). PPARG2, peroxisome proliferator-activated 
receptor γ2; G0s2, G0/G1 switch 2; FABP4, fatty acid binding protein 4; GLUT4, glucose 
transporter 4; LPL, lipoprotein lipase.  
(F) Ectopic expression of miR-103 or miR-143 hastens expression of adipogenic markers 
at day 2 (D2). Data are expressed as mean ± SEM (n=4). *** P < 0.001, **P < 0.01, *P 




In this study, we have generated a comprehensive database of the expression patterns of 
over 370 known mouse mature miRNAs during normal fat cell development and, for the 
first time, in adipocytes from normal and obese mice. Similar changes in miRNA 
expression occur during in vitro and in vivo adipogenesis. Many of these differentially 
regulated miRNAs are likely to be important in adipose biology, as we showed that 
ectopic expression of two normally upregulated miRNAs, miR-103 or miR-143, in 
preadipocytes accelerates the rate of fat cell formation.  Importantly, miRNAs that were 
induced during adipogenesis were decreased in adipocytes from both types of obese mice 
and vice versa. We suggest that these changes are linked to the chronic local 
inflammation environment and enhanced TNFα levels in obese adipose tissue, since 
similar changes in the pattern of miRNA expression occurred following TNFα treatment 
of differentiated adipocytes. Our work provides an important first step towards 
construction of the entire RNA regulatory network underlying fat cell development and 
adipose dysfunction in obesity. An understanding of the role of miRNAs in adipose 
biology may lead to novel RNA-based therapies that complement current anti-obesity 
treatments. 
 
Regulated expression of functionally important miRNAs  
Our genome wide miRNA profiling study identified many differentially regulated 
miRNAs, including miR-103 and miR-143. miR-143 is likely to be important in 
adipocyte biology, since transfection of antisense miR-143 oligonucleotides in cultured 
human preadipocytes inhibits all five adipocytes differentiation markers by at least 40% 
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(Esau et al., 2004). Our experiments ectopically expressing miR-143 resulted in the 
opposite effect, upregulation of adipogenesis markers, thus confirming its important role 
in modulating adipogenesis.  
 
Wang et al reported that the miR-17-92 cluster is up-regulated two fold only during the 
early clonal expansion stage of adipogenesis, and that these miRNAs accelerate adipocyte 
differentiation by negatively regulating p130 (Wang et al., 2008). Since we focused only 
on miRNAs upregulated during adipose differentiation per se, our microarray analyses 
did not identify the miR-17-92 cluster as significantly upregulated. We did not focus on 
miRNA changes during the clonal expansion phase in part because there are no primary 
cell samples corresponding to this stage. In addition, according to our microarray data the 
miR-17-92 cluster is not abundantly expressed in differentiated adipocytes.  
 
Importantly, we also studied purified primary adipocytes, which are more homogeneous 
than the unfractionated primary adipose tissue used in an earlier study (Gu et al., 2007); 
this enabled us to identify adipocyte enriched miRNAs. Comparing the 44 miRNAs most 
highly expressed in epididymal adipocytes from normal mice with the 29 miRNAs most 
highly expressed in chondrocytes and osteoblasts (Kobayashi et al., 2008), expression of 
18 miRNAs including let-7, miR-23, miR-26 and miR-30, are common to all three 
lineages. This suggests that they are functionally important for differentiation of all three 
cell types – adipocytes, chondrocytes, and osteoblasts – that are formed from 
mesenchymal stem cells (Pittenger et al., 1999). In contrast, miRNAs preferentially 
enriched in one particular mesenchymal lineage may have roles in cell fate determination 
 41
and lineage differentiation of mesenchymal stem cells or be required for the function of 
these differentiated cells. As example, miR-140 is enriched in osteoblasts and 
chondrocytes and miR-140 was reported previously to be important for bone 
development by downregulating histone deacetylase 4 (Tuddenham et al., 2006).  
 
Downstream effectors and targets for miR-103 and miR-143 
A computational study predicted that the miRNA paralogs miR-103 and miR-107 affect 
multiple mRNA targets in pathways that involve cellular acetyl-CoA and lipid 
metabolism (Wilfred et al., 2007). Appendices 1 and 2 suggest many potentially 
important mRNA targets for miR-103 and miR-143, including several anti-adipogenic 
factors such as ARNT, FZD1 and RUNX1T1/ETO/MTG8 whose levels are normally 
downregulated during adipogenesis. These genes were selected based on meeting all of 
the following criteria: (1) Expressed in 3T3-L1 cells at day 0 or day 2; (2) A lower 
mRNA expression level in day 2 cells in which miRNA is ectopically expressed 
compared to control cells at day 2; (3) Predicted targets based on TargetScan 
v4.2(Grimson et al., 2007; Lewis et al., 2005).  
 
Some targets not listed here may have decreased protein levels but unchanged mRNA 
levels; some may be predicted by computational softwares other than Targetscan. 
Importantly, miRNAs likely target many mRNAs (Baek et al., 2008; Selbach et al., 2008) 
and defining one major target of either miRNA will be difficult and likely impossible. 
For example, many miR-143 targets shown in Appendix 2 are equally if not more 
interesting than MAPK7/ERK5, which was previously suggested as a miR-143 target 
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(Esau et al., 2004). Validation of potential targets by luciferase reporter assays and 
western blots is ongoing but beyond the scope of this paper.  
 
Functionally important adipocyte miRNAs are downregulated in obesity, likely due 
to macrophage infiltration and TNFα 
Most strikingly, several miRNAs, including miR-103 and miR-143, exhibit inverse 
patterns of regulation during adipogenesis compared to those during obesity (Figure 2-
4A), indicating that obesity leads to a loss of miRNAs that characterize fully 
differentiated and metabolically active adipocytes. Earlier studies reported that many 
adipogenic genes whose expression increases during adipogenesis, displayed markedly 
decreased expression in adipocytes from epididymal fat pads of ob/ob and DIO mice 
(Moraes et al., 2003; Nadler et al., 2000; Soukas et al., 2000).  
 
In general, we observed a greater extent of miRNA dysregulation in adipocytes from 
ob/ob compared to DIO mice. In parallel, several groups reported a greater change of 
altered mRNA expression in adipocytes from ob/ob compared to DIO mice (Moraes et al., 
2003; Nadler et al., 2000; Soukas et al., 2000). This is likely due to the fact that ob/ob 
mice have increased adiposity compared to DIO mice of the same age (data not shown). 
Alternatively, three months of a high fat diet might not be long enough to induce the 
same changes as seen in adipocytes from ob/ob mice. Nevertheless, the positive 
correlation of miRNA regulation we observed in these two different models of obesity 
(Figure 2-3D) suggests that the changes in the adipocyte miRNA expression profile in 
ob/ob mice cannot result from leptin deficiency alone.  
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More likely these changes are associated with the chronic inflammatory environment in 
obese adipose tissue. Increased expression of inflammation-related genes was found in 
isolated abdominal subcutaneous adipocytes and cultured stromal vascular cells from 
obese Pima Indians compared with non-obese controls (Lee et al., 2005; Nair et al., 2005). 
We hypothesize that one or more miRNAs upregulated upon TNFα treatment of 
adipocytes are involved in destabilizing PPARγ or CCAAT/enhancer-binding protein α 
or another mRNA encoding an adipocyte-important transcription factor.  
 
Ruan et al reported that TNFα suppressed adipocyte-specific genes and activated 
expression of preadipocyte genes in 3T3-L1 cells (Ruan et al., 2002). In parallel, we 
showed here that in 3T3-L1 adipocytes TNFα repressed miRNAs that are normally 
upregulated during adipogenesis. Thus, elevated levels of TNFα in obese adipose tissue 
are likely the cause of the changes in miRNA levels we observed in obesity. Our results 
(Figure 2-5) also suggested that obesity had a much stronger impact on the expression of 
these miRNAs than did exposure of 3T3-L1 cells to TNFα. These differences are 
probably due to the relatively long half-life of miRNAs and some delay in transcription in 
response to TNFα treatment. Additionally, the chronic inflammatory state of obese 
adipose tissue likely depends on other inflammatory cytokines such as IL-6, leading to 





miRNAs are highly connected nodes in regulatory networks underlying 
adipogenesis and adipose dysfunction in obesity  
Only a small fraction of known miRNAs is significantly regulated during adipogenesis 
(Figure 2-1A). However, each miRNA is thought to regulate, on average, about 200 
target genes and has widespread impact on protein output (Baek et al., 2008; Selbach et 
al., 2008). Multiple miRNAs can act additively or synergistically at multiple target sites 
on a single mRNA (Krek et al., 2005). The potential interaction networks connecting 
miRNAs and mRNAs are enormous and can be further expanded by feedback or feed 
forward loops (Shalgi et al., 2007). Whereas miR-103 and miR-143 have been suggested 
to be important for adipogenesis, little is known about the specific mRNA targets of these 
miRNAs. Their effects on adipogenesis could be achieved by significant downregulation 
of one or two “primary” target mRNAs or by more modest downregulation of perhaps 
hundreds of preadipocyte-important mRNAs. Clearly we need to identify biologically 
relevant targets for these key miRNAs. In the reconstructed regulatory network, each 
miRNA will likely link to multiple target genes and serve as a controlling point and 
potential target for therapeutic intervention. 
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Chapter 3. MicroRNAs in lineage determination between white 
fat, brown fat and muscle  
3.1 Abstract 
To decipher the role of microRNAs (miRNAs) in brown fat cell development, we 
profiled the genome-wide miRNA expression patterns of white fat, brown fat, and 
skeletal muscle. Interestingly, many “myogenic” miRNAs were abundant in brown fat 
but absent in white fat, which is consistent with the current notion that during lineage 
specification the brown adipocyte precursor is closer to the muscle precursor than the 
white adipocyte precursor. We identified several miRNAs that were preferentially 
expressed in only one of the three tissue types. Strikingly, ectopic expression of miR-193, 
a brown fat-enriched miRNA, in myogenic C2C12 cells inhibited myotube maturation, as 
evidenced by absence of key muscle morphological changes and also reduced expression 
of key myogenic proteins. Mechanistically, this miRNA exerts effect through direct 
downregulation of pro-myogenic target genes. Taken together, our results underlie the 
importance of tissue enriched miRNAs in regulating lineage specification between brown 
fat and muscle. 
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3.2 Introduction  
Adipose tissue consists of white adipose fat (WAT) and brown adipose fat (BAT), which 
exhibit distinct transcription profiles and metabolic properties. While WAT stores excess 
energy as triacylglycerol, BAT is very active in energy expenditure through adaptive 
thermogenesis and has an anti-obesity function (Gesta et al., 2007; Seale et al., 2009). 
Using morphological studies and positron-emission tomography (PET) scanning studies, 
three independent groups have recently demonstrated that adult humans have substantial 
amounts of functioning BAT (Cypess et al., 2009; van Marken Lichtenbelt et al., 2009; 
Virtanen et al., 2009). Importantly, the amount of BAT negatively correlates with both 
BMI and percentage of body fat, whereas it positively correlates with resting metabolic 
rate. It is also estimated that 50 g of BAT, if maximally stimulated, could account for 
20% of daily energy expenditure (Rothwell and Stock, 1983).Thus, the ability to change 
even small amount and activity of BAT holds exciting therapeutic potential for obesity 
and related disorders.  
 
Most strikingly, myogenic gene expression signature and lineage tracing experiments 
suggest that white and brown adipocytes originate from different precursors with brown 
preadipocytes being more closely related to skeletal muscle cells (Atit et al., 2006; 
Moulin et al., 2001; Seale et al., 2008; Timmons et al., 2007). However, little is known 
about the regulation of lineage specification between BAT and muscle as well as the 
molecular mechanisms underlying contrasting metabolic properties between WAT and 
BAT. Potential regulators include microRNAs (miRNAs), which encode an abundant 
class of ∼22 nucleotide evolutionarily conserved RNAs that control gene expression at 
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the posttranscriptional level by targeting mRNAs for degradation or translational 
repression or both (Ambros, 2004; Baek et al., 2008; Bartel, 2004, 2009; Selbach et al., 
2008).  
 
The expression of miRNAs is often tissue-specific or developmental-specific (Ambros, 
2004; Bartel, 2004). miRNAs play important roles in development and lineage 
specification. For example, lsy-6 and miR-273 control left-right asymmetry in the ASE 
neurons during neural development of C. elegans (Chang et al., 2004; Johnston and 
Hobert, 2003). During differentiation of mESC derived neural progenitors, modulation of 
the relative levels of brain-specific miR-124a and miR-9, both brain-enriched miRNAs, 
alters the ratio of cells of the glial versus neuronal lineages (Krichevsky et al., 2006). In 
addition, pancreatic islets specific miR-375 is required to maintain normal alpha and beta 
cell mass miR-375 knock-out mice exhibit increased alpha cell numbers but decreased 
beta cell numbers (Poy et al., 2009).  
 
Since signature miRNA expression patterns differentiate many types of related cancers 
better than more classical analyses of mRNA profiles or protein markers (Lu et al., 2005), 
we aim to identify unique miRNA signatures associated with WAT, BAT and skeletal 
muscle respectively using global expression analysis. We found that miR-193 is 
preferentially expressed in BAT. To characterize its function in lineage specification and 
brown fat function, we ectopically expressed miR-193 in myoblast cells. Ectopic 
expression of miR-193 is able to inhibit myotube maturation. Our work provides the first 
example of miRNA regulating lineage specification between brown fat and muscle. An 
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understanding of the role of miRNAs in adipose tissue development may lead to novel 
RNA-based therapies that complement current anti-obesity treatments. 
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3.3 Materials and methods  
Cell culture, differentiation and chemical treatments 
Immortalized brown fat preadipocytes (BAT) from R. Kahn were cultured as described 
previously (Fasshauer et al., 2000). Brown adipocyte differentiation was induced by 
treating confluent cells in medium containing 10% FBS, 1 μM dexamethosone, 0.5 mM 
isobutylmethylxanthine, 125 nM indomethacin, 160 nM insulin, 1 nM T3. Two days after 
induction, cells were switched to maintenance medium containing 10% FBS, 160 nM 
insulin, 1 nM T3. To stimulate thermogenesis, cells were incubated with 0.5 mM dibutyrl 
cyclic-AMP for 4 hours. All chemicals for cell culture were obtained from Sigma, unless 
otherwise indicated. C2C12 cells from American Type Culture Collection (ATCC) were 
cultured and differentiated according to the instruction.  
 
Mouse studies  
Male C57BL/6J mice (Jackson Laboratory) were maintained at the animal facility of the 
Whitehead Institute for Biomedical Research. All animal experiments were performed 
with the approval of the Massachusetts Institute of Technology Committee on Animal 
Care. Epididymal WAT, interscapular BAT and skeletal muscle were harvested for 
miRNA expression profiling. Primary brown adipocytes and stromal vascular cells were 
obtained after collagenase digestion according to published protocol (Cannon and 





miRNA microarray and data analysis  
Total RNA including miRNA was extracted using a miRNeasy Mini kit according to the 
manufacturer's protocol (Qiagen). Total RNA (5 μg) was size-fractionated, and the small 
RNAs (<300 nt) isolated were 3′-extended with a poly(A) tail using poly(A) polymerase 
and labeled with Cy5. Hybridizations were performed on a microfluidic biochip platform 
(LC sciences). Microarrays with miRNA content corresponding to miRBase v10.1 (six 
probes for each miRNAs on one chip) were used. Data were analyzed by first subtracting 
the background and then normalizing the signals using a LOWESS filter across all the 
arrays. miRNAs with an intensity more than 500 arbitrary units were considered as 
expressed. Differentially regulated miRNAs were identified by one-way ANOVA 
analysis (P < 0.1). 91 miRNAs expressed in at least one sample and differentially 
expressed between three tissues were selected for clustering analysis. Unsupervised 
hierarchical clustering was performed with average linkage and uncentered correlation as 
the similarity metric using Cluster3.0 (de Hoon et al., 2004). Heat map was generated in 
Java Treeview (de Hoon et al., 2004). Complete miRNA microarray data and detailed 
protocols are deposited into Array Express.  
 
Quantitative real time RT-PCR assay 
For miRNA RT-PCR, 10 ng RNA was reverse-transcribed, and individual Taqman 
primers were used for PCR according to the manufacturer's instruction (Applied 
Biosystems). snoRNA202 was used as the internal control. For mRNA RT-PCR, 1 μg 
RNA was reverse-transcribed with random primers by SuperScript II Reverse 
Transcriptase (Invitrogen) and PCR amplified with gene-specific primers and SYBR 
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Green PCR master mix using ABI 7900HT according to the manufacturer's protocol 
(Applied Biosystems). 18S was used as the internal control. Data were analyzed by the 
relative quantification (ΔΔCt) method.  
 
miRNA gene cloning and ectopic expression 
Authentic miRNA stem-loop and flanking sequences on the 5′ and 3′ side of the mature 
miR-193 was amplified from normal mouse genomic DNA (Clontech) and cloned into a 
retroviral vector containing IRES-GFP as described previously (Zhang and Ren, 1998). 
Empty vector or expression plasmid with miRNA (8 μg) was co-transfected into 293T 
cells with retrovirus packaging vector pCL-Eco (4 μg) using FuGene 6 according to the 
manufacturer's protocol (Roche). Virus supernatant was collected and used to infect 3T3-
L1 cells with the addition of polybrene (Sigma) to a final concentration of 4 μg/ml. 
Infection efficiency is generally higher than 80%. For stable miRNA expression, infected 
cells were sorted by fluorescence-activated cell sorting to collect the GFP+ cells.  
 
Luciferase reporter assay 
About 400 bp segments containing predicted miRNA target site in the 3’UTR of CDON 
and IGFBP5 were cloned into the psiCHECK-2 vector (Promega) between the XhoI and 
NotI sites immediately downstream of the Renilla luciferase gene. To generate reporter 
with seed mutant 3’UTR, five nucleotides (CCAGT) in the target site complementary to 
the position 2-6 of miR-193 seed region were mutated to GATCC by QuickChange Site-
Directed Mutagenesis kit according to the manufacturer's protocol (Stratagene). 293T 
cells were seeded in 96-well plates (Corning) at a density of 30,000 cells per well one day 
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before transfection. Ten nanograms of each reporter construct was co-transfected with 
miR-193 mimic or a mimic control at final concentration 50nM into 293T cells using 
Lipofectamine 2000 according to the manufacturer's protocol (Invitrogen). After 48 hours, 
firefly and Renilla luciferase activities were measured with the Dual-Glo luciferase assay 
system according to the manufacturer’s instructions (Promega). 
 
Statistical Analysis 
Data are expressed as means ± SEM unless otherwise indicated. Student's t test (unpaired, 
two-tailed) was used to compare the two groups and One-way ANOVA analysis was 
used to compare multiple groups. P value was calculated in Excel (Microsoft) or 





miR-193 is preferentially expressed in brown fat  
We profiled the expression of 569 miRNAs (miRbase v10.1) in mouse epididymal WAT, 
interscapular BAT and skeletal muscle using miRNA microarrays. Based on criteria 
described in the Materials and Methods section, 91 miRNAs were expressed in at least 
one sample, as defined by having an intensity more than 500 arbitrary units, and 
differentially expressed between three tissues (Figure 3-1, P < 0.1, ANOVA). Results 
from microarrays were further validated by quantitative RT-PCR assays (data not shown). 
Most importantly, many “myogenic” miRNAs such as miR-1, miR-133 and miR-206 
were abundant in BAT but absent in WAT. Strikingly, among other miRNAs, miR-193 
was preferentially expressed in BAT as compared to WAT and skeletal muscle; thus we 
focused on miR-193 for our further analysis. As shown in Figure 3-2A and B, miR-193 
level in WAT and skeletal muscle was 61% and 22% relative to that in BAT based on 
RT-PCR results.  
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Figure 3-1. miRNA expression profiling in WAT, BAT and skeletal muscle.   
Heat map showing the expression levels of 91 miRNAs that are expressed in at least one 
sample (Intensity > 500 arbitrary units) and differentially expressed between the three 
tissues (P < 0.1, ANOVA). Red denotes higher and green denotes lower relative to the 
mean of the six samples for each miRNA.  
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miR-193 expression increases specifically during brown adipocyte differentiation 
To examine whether miR-193 is regulated during differentiation, we quantified using RT-
PCR its level before and after brown adipocyte differentiation and C2C12 myoblast 
differentiation. Before differentiation, miR-193 levels in brown preadipocytes and C2C12 
myoblasts are comparable (Figure 3-2C). Interestingly, miR-193 expression increased 
around 8-fold during the differentiation of brown preadipocytes in culture (Figure 3-2C). 
In contrast, miR-193 expression did not change substantially during differentiation of 
C2C12 myoblasts (Figure 3-2C). In addition, miR-193 expression was not affected by 
cAMP treatment of differentiated brown adipocytes (data not shown), suggesting that 
miR-193 is not involved in thermogenesis.  
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Figure 3-2. RT-PCR analysis of miR-193 family expression in WAT, BAT and skeletal 
muscle and its expression during brown adipocyte differentiation.  
(A) miR-193 expression in WAT, BAT and skeletal muscle. Expressions are shown 
relative to the level in BAT.  
(B) miR-193b expression in WAT, BAT and skeletal muscle. Expressions are shown 
relative to the level in BAT. 
(C) miR-193 expression increases during brown adipocyte differentiation but not C2C12 
myoblast differentiation. Expressions are shown relative to the level in brown 
preadipocytes at Day 0 (D0). Data are expressed as mean ± SEM (n=3). 
 
Ectopic expression of miR-193 inhibits C2C12 myotube maturation 
To decipher the role of miR-193 in the lineage determination between BAT and muscle 
during development, we used a retroviral vector to stably express miR-193 in C2C12 
cells. The infection rate was approximately 85% based on GFP expression (data not 
shown). miR-193 virus infected cells expressed approximately 7 fold higher levels of 
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mature miRNA compared to control cells that expressed the empty vector alone, which 
was comparable to that of primary brown adipocyte (Figure 3-3A). Thus miR-193 was 
ectopically expressed at physiological level. 
 
First, C2C12 myoblasts were infected with control or miR-193-expressing retroviruses, 
and then exposed to pro-myogenic culture conditions to induce terminal differentiation. 
At day 6, C2C12 cells expressing the control virus differentiated efficiently into 
elongated multinucleated myotubes whereas miR-193-expressing cells failed to undergo 
myotube maturation, forming very few myosin positive myotubes (Figure 3-3B and C). 
Gene expression analysis by RT-PCR showed that ectopic expression of miR-193 
repressed many myotube-specific genes including Myog, Myf5, Myf6, Ckm, Myl1, 
Casq1, Tnni2 and Tnnt3 although did not affect Myod1 mRNA (Figure 3-3D). 
Furthermore, miR-193-expressing C2C12 cells had higher mRNA levels of fat markers, 
such as Pparg, Lpl, Cebpd and Cebpa before myogenesis and ectopic expression of miR-




Figure 3-3. Ectopic expression of miR-193 in C2C12 myoblasts inhibits myotube 
maturation.  
(A) Expression level of miR-193 in virus infected C2C12 cells compared to vector 
control and primary brown adipocytes. miRNA levels are measured by RT-PCR and 
shown relative to the level in primary brown adipocytes. Data are expressed as mean ± 
SEM (n=3). 
(B) C2C12 cells ectopically expressing miR-193 differentiate defectively in culture. 
(C) Ectopic expression of miR-193 in C2C12 cells reduces myosin positive myotubes by 
immunofluorescence. Nucleus is stained by DAPI.  
(D) Ectopic expression of miR-193 in C2C12 myoblasts inhibits induction of muscle 
specific genes at day 6 of myogenesis. Expressions are shown relative to the level in 
vector controls. Data are expressed as mean ± SEM (n=3). ** P < 0.01, * P < 0.05. 
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CDON and IGFBP5 are direct and functional targets of miR-193 in blocking 
myotube maturation 
To understand the mechanisms by which miR-193 blocked myotube maturation, we used 
TargetScan to predict potential miR-193 targets in mouse. Among the 108 conserved 
targets, CDON (also named CDO) and IGFBP5 were previously implicated as pro-
myogenic factors. To examine whether CDON and IGFBP5 are direct targets of miR-193, 
we inserted wild-type 3’UTR or seed mutant 3’UTR (3’UTR_mut) downstream of a 
luciferase reporter gene. These construct plasmids were co-transfected with miRNA 
mimic into 293T cells, and luciferase activity was quantified after 2 days. miR-193 
reduces the luciferase activity of the CDON and IGFBP5 reporters with wild-type 3’UTR 
by 40% and 60% respectively in comparison to reporters with seed mutant 3’UTR 
(3’UTR_mut) (Figure 3-4). These data indicate that transfected miR-193 bound to the 
target sites of wild-type 3’UTR and repressed gene expression; these data also suggest 
that the predicted seed region is necessary for the binding of miR-193 to the target sites. 
Thus, phenotype of the miR-193-expressng cells can be at least partially due to the direct 




Figure 3-4. Pro-myogenic factors, CDON and IGFBP5, are direct targets of miR-193.  
miR-193 reduces the luciferase activity of the CDON and IGFBP5 reporters with wild-
type 3’UTR but not seed mutant 3’UTR (3’UTR_mut). Renilla luciferase activity is 
measured by Dual-Glo luciferase assay system, normalized to internal control firefly 
luciferase activity and shown relative to the level in reporter with seed mutant 3’UTR. 
Data are expressed as mean ± SEM (n=6). *** P < 0.001, ** P < 0.01. 
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3.5 Discussion 
In this study, we have generated a comprehensive database of the expression patterns of 
569 known mouse mature miRNAs in WAT, BAT and skeletal muscle. We further 
identified unique miRNA signature associated with each type of tissues. Interestingly, 
many “myogenic” miRNAs are abundant in brown fat but absent in white fat, which is 
consistent with the notion that brown adipocyte precursor is closer to muscle precursor 
than white adipocyte precursor during lineage specification. In addition, many of other 
tissue enriched miRNAs likely contribute to the lineage differentiation and/or distinct 
transcription profiles and metabolic properties as we have demonstrated that ectopic 
expression of miR-193 inhibited C2C12 myotube maturation. Further functional 
characterization of mir-193 in animal models and better understanding of the mechanisms 
of regulating brown fat development may lead to identification of novel therapeutic 
targets and strategies against obesity and related metabolic disorders. 
 
Developmental origin of brown adipose tissue  
White and brown adipose tissue have long been assumed to share a common 
developmental origin because they both undergo a similar differentiation program and 
express common enzymes for lipid metabolism (Gesta et al., 2007; Rosen and 
Spiegelman, 2000). However, emerging evidences favor the model that brown adipocyte 
precursor is closer to muscle precursor than white adipocyte precursor during lineage 
specification. A lineage tracing experiment using the UCP1 promoter has demonstrated 
that white adipocytes are distinct from brown adipocytes during normal development 
(Moulin et al., 2001). Another fate mapping experiment has shown that BAT, dermis and 
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some skeletal muscles are derived from a precursor expressing Engrailed 1 (En1) (Atit et 
al., 2006). Most recently, only BAT and skeletal muscle but not WAT are shown to be 
derived from precursors expressing myogenic factor 5 (Myf5) (Seale et al., 2008). In 
addition, brown preadipocytes have been reported to possess a “myogenic” 
transcriptional signature (Timmons et al., 2007). Our genome-wide miRNA profiling in 
this study together with others further reveals that BAT expresses many “myogenic” 
miRNAs, providing insights into another layer of regulation controlling the 
developmental origin of BAT.  
 
miRNAs preferentially expressed in a specific tissue  
We have identified groups of miRNAs preferentially expressed in different tissues. Their 
tissue specific expression pattern may be attributed to many factors. For example, 
“myogenic” miRNAs such as miR-1, miR-133 and miR-206 are abundant in BAT. This 
is unlikely due to muscle contamination in the BAT during sample preparation as MYF6 
is almost undetectable in BAT (data not shown). Another group also independently 
reports these “myogenic” miRNAs are expressed both in brown pre- and mature 
adipocytes (Walden et al., 2009). It is likely that their expressions are turned on early in 
the development stage and remain in the mature brown adipocytes. Whether these 
miRNAs are functional important for mature brown adipocytes needs further 
investigation. In contrast, muscle enriched miR-196, a vertebrate specific miRNA 
expressed from intergenic regions of HOX gene clusters, has been shown to cleave 
Hoxb8 and act upstream of Sonic hedgehog (Shh) in limb development in a fail-safe 
mechanism (Hornstein et al., 2005). Moreover, some miRNAs enriched in one tissue are 
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due to the host gene expression. For instance, miR-378 is in the intron of PPARγ 
coactivator-1β (PGC-1β), which is preferentially expressed in muscle and BAT (Lin et al., 
2002; Meirhaeghe et al., 2003) while miR-335 lies in the intron of mesoderm specific 
transcript (MEST), a marker of adipocyte size whose expression is high in WAT but low 
in BAT and muscle (Takahashi et al., 2005). Interestingly, computational predictions and 
experimental studies suggests tissue enriched miRNAs can repress tissue-specific 
mRNA(s), many of which are involved in lineage determination and are responsible for 
their contrasting metabolic functions – energy storage versus energy expenditure. For 
example, miR-30, miR-365 and miR-455 are enriched in BAT and predicted to target 
NRIP1, which is preferentially expressed in WAT relative to BAT. Whether they act 
additively or synergistically with miR-193 awaits further investigation. In addition, miR-
30 is predicted to target muscle specific actin-binding protein cofilin-2 (CFL2) while 
miR-365 is predicted to target myosin light chain kinase (MYLK). On the contrary, WAT 
enriched miR-130 has been shown to repress mesenchyme homeobox 2 (MEOX2) (Chen 
and Gorski, 2008), whose expression is higher in BAT and muscle compared to WAT.  
 
miR-193 and PRDM16 
PRDM16 has been previously identified as a BAT enriched protein controlling a brown 
fat/skeletal muscle switch (Seale et al., 2008; Seale et al., 2007). Depletion of PRDM16 
in primary brown fat cells causes the loss of the brown fat characteristics and induces 
skeletal muscle differentiation. On the other hand, overexpression of PRDM16 in C2C12 
leads to lipid droplet accumulation. Our results demonstrated that miR-193 inhibits 
skeletal muscle myotube maturation but is not sufficient to stimulate brown adipocyte 
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differentiation in C2C12 (Figure 3-3 and data not shown). Whether miR-193 is a 
downstream effector of PRDM16 or acts independently from PRDM16 in regulating 
lineage specification between brown fat and muscle remains to be elucidated. However, 
ectopic expression of miR-193 does not induce PRDM16 (data not shown), suggesting 
that miR-193 does not act upstream of PRDM16.  
 
Downstream effectors of miR-193 
In this study, we have used luciferase reporter assays to show that miR-193 may exert its 
function by directly repressing the conserved targets CDON and IGFBP5. CDON is a cell 
surface receptor that stimulates post-translational activation of myogenic bHLH factors 
and E proteins, and increases muscle-specific transcription (Cole et al., 2004; Kang et al., 
1998). Importantly, knocking down of CDON by RNAi in C2C12 reduces myosin 
positive myotubes while primary myoblasts from Cdon-/- mice differentiate defectively in 
culture, expressing reduced levels of myogenin and forming very few myotube syncytia 
(Cole et al., 2004; Kang et al., 2008). IGFBP5 is another protein that can promote 
myogenesis. Knocking down IGFBP5 impairs myogenic differentiation of C2C12 and 
primary skeletal muscle cells (Ren et al., 2008). Thus, the inhibition of myotube 
maturation by miR-193 could be partially attributed to its repression on CDON and 
IGFBP5.  Since miRNAs can target multiple mRNAs, it is highly possible that miR-193 
repress additional direct targets, whose functions are not well characterized yet. Large 
scale transcriptome and proteome comparison between miR-193 overexpressing cells and 
controls will help identify other biologically relevant potential targets and downstream 
effectors.  
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Role of miR-193 in brown adipocyte differentiation and function 
Although miR-193 is preferentially expressed in BAT and induced during brown 
adipocyte differentiation, ectopic expression of miR-193 in brown preadipocytes does not 
accelerate adipogenesis (data not shown). Further experiments are needed to decipher 
whether miR-193 is involved in mature brown adipocyte functions such as adaptive 
thermogenesis, glucose uptake and lipid metabolism. Notably, 3’UTR of ATP5F1, a gene 
encoding a subunit of mitochondrial ATP synthase, contains a target site that is partially 
complementary to miR-193. Besides the role of miR-193 in lineage specification during 
brown fat development, it is tempting to hypothesize that miR-193 may tune the level of 
mitochondrial ATP synthase when in need to favor heat production instead of ATP 
synthesis in brown adipocytes.   
 
Therapeutic potential of brown fat 
The role of BAT in regulating energy balance and fighting obesity in rodents is well 
established. The anti-obesity role of BAT is supported by many evidences. First, genetic 
ablation of BAT in mice results in hyperphagia and obesity (Lowell et al., 1993). Second, 
UCP1 knockout mice develop obesity when housed at thermoneutrality (Feldmann et al., 
2009). In contrast, experimental increases in the amount and/or function of brown fat 
promotes a lean and healthy phenotype (Cederberg et al., 2001; Kopecky et al., 1995; 
Kopecky et al., 1996). Stimulation of brown fat mediated thermogenesis by 
pharmacological treatment with β-adrenergic agonists reduces obesity (Himms-Hagen et 
al., 2000), but these agents have too many adverse side effects (Arch, 2002). Because 
miR-193 is involved in brown fat development, in vitro and in vivo manipulation of miR-
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193 and other brown fat enriched miRNAs, independently or together with other 
transcription factors including PRDM16, may help confer the properties of brown 
adipocyte to white adipocyte or muscle cells, which can be used clinically to raise whole 
body energy expenditure and prevent excess fat accumulation. 
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Chapter 4. Future directions 
4.1 Signaling pathways downstream of TNFα in regulating microRNA 
in obese adipocytes 
Our results suggested that miRNA changes associated with obesity was at least partly due 
to TNFα. Ruan et al reported that TNFα suppressed adipocyte-specific genes and 
activated expression of preadipocyte genes in 3T3-L1 cells via activation of the NF-κB 
pathway (Ruan et al., 2002). However, it is unclear whether NF-κB pathway is 
responsible for miRNA dysregulation. To address this, we can generate 3T3-L1 cells 
stably expressing dominant negative of NF-κB constructed by Ruan et al (Ruan et al., 
2002). After adipogenic differentiation, TNFα treatment can be applied. Expression of a 
panel of selected miRNAs shown in Figure 2-5 can be compared in adipocytes expressing 
dominant negative of NF-κB with adipocytes expressing vector control. If blocking NF-
κB pathway can abolish the regulation of miRNA by TNFα, NF-κB pathway is essential 
downstream of TNFα in regulating miRNA in obese adipocytes.  
 
4.2 Functional targets of miR-103 and miR-143 
We have generated a list of candidate targets of miR-103 and miR-143 mediating 
acceleration of adipogenesis by microarray analysis and computational target prediction. 
Large scale proteomics will help identify targets of a specific miRNA since the effect of 
miRNAs is often more pronounced at the protein level than at the mRNA level. Improved 
computational algorithms predicting miRNA targets will aid in this effort as well. 
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Potential candidate targets can be further validated by luciferase reporter assay and 
Western blot. For luciferase reporter assay, 3’UTR of the putative target gene can be 
cloned downstream of the Renilla luciferase gene in the psiCHECKTM-2 vector 
(Promega). The repression by miRNA can be monitored with Dual-GloTM Luciferase 
assay system (Promega) after co-transfection of the miRNA mimic and reporter 
constructs into 293T cells for 48 hours. Also, a reporter gene containing mutations in the 
miRNA target site and a miRNA mimic control will be included as controls. If the 
selected candidate is a true miRNA target, a reduction in the luciferase signal should be 
observed when the tested miRNA mimic is used but not when a mutated 3’UTR or a 
miRNA mimic control is used. In addition, a western blot can be carried out if the 
antibody is available.  
 
4.3 Loss of function studies of microRNA 
In the present study, we characterized many miRNAs mainly be gain-of-function 
approach. Future work can assess their function by loss-of-function approach in vitro and 
in vivo. In cell culture, miRNA activity can be knocked down with antisense 
oligonucleotides with modifications to increase stability and binding specificity. Three 
major types of modifications includes 2’-O-methyl (2’-O-Me), 2’-O-methoxyethyl (2’-O-
MOE) oligonucleotides and locked nucleic acids (LNAs). We can transfect antisense 
oligonucleotides for a tested miRNA (Dharmacon) into 3T3-L1 cells or brown 
preadipocyte cells and assess the effect on adipogenesis and adipocyte function after 
hormone induction. An alternative approach of silencing miRNAs is the use of miRNA 
sponges, which contain multiple tandem binding sites for targeted miRNAs, thereby 
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acting as decoys to titrate miRNAs away from their natural targets (Ebert et al., 2007). 
When miRNA sponges are expressed as a plasmid, the effect can be long lasting.  
In addition, miRNA activity can be knocked down in vivo with LNAs or antagomirs, 
which are cholesterol-conjugated 2’-O-Me oligonucleotides. However, it is still 
challenging to deliver them specifically and efficiently into adipose tissue.  In the long 
term, total and adipocyte-specific miRNA knockout mice can be generated.  We can 
monitor the body weight, adipose mass, size distribution of adipocytes with histological 
staining, serum metabolites for markers of insulin resistance and their tolerance to high-
fat diet. These knockout mice will also facilitate the identification of functional targets. 
However, it is challenging to knockout all miRNA family members that are regarded to 
be functionally redundant if these family members are not on the same chromosome. For 
example, miR-103/107 family members, miR-103-1, miR-103-2 and miR-107, reside on 
three different chromosomes.  
 
4.4 Role of microRNA in adipocyte functions  
Our study has identified many miRNAs enriched in adipose tissue, regulated during 
adipogenesis and dysregulated in obese adipose tissue. Future work can reveal their roles 
in adipocyte functions, namely glucose uptake, lipid metabolism and adipokine 
production. With the ectopic expression system described in the present study, we 
perform insulin-stimulated glucose uptake assays and lipolysis assay on miRNA 
overexpressing adipocytes. We can also check the adipokine production in the medium 
by ELISA upon ectopic expression of certain miRNA.  
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4.5 Combinatorial effect of microRNAs 
It is well established that several different miRNAs can act additively or synergistically at 
multiple target sites of a single mRNA or several mRNAs along a pathway (Krek et al., 
2005). The effect of single miRNA may be small and difficult to detect; nonetheless each 
probably makes an important contribution to the robustness of the development of 
metabolic tissues and pathogenesis of obesity and associated disorders. In the future, one 
can manipulate multiple candidate miRNAs in different combinations rather than 
changing one miRNA at a time for functional characterization. However, this is labor 
intensive and technically challenging at present.  
 
4.6 Upstream regulators of microRNA expression  
We have identified many miRNAs regulated during adipogenesis and dysregulated in 
obese adipose tissue as well as several miRNAs that are enriched in brown fat. However, 
little is known about the upstream transcription factors controlling their expression. 
Computationally, we can first identify the transcription unit of a miRNA based on their 
genomic location and EST data. More publically available genome-wide Chromatin 
Immunoprecipitation – sequencing (ChIP-seq) data for polymerase II and histone marks 
will aid in this effort. Upstream genomic sequence of the transcription unit can be 
extracted and analyzed with bioinformatic tools for evolutionarily conserved and 
overrepresented motifs, which may be transcription factor binding sites. ChIP-PCR can 
be used to verify experimentally the regulation of a specific miRNA by a particular 
transcription factor.  
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Appendix 1. List of putative target genes of miR-103 at the early stage of 3T3-L1 
differentiation. These genes meet all of the following criteria: (1) Expressed in 3T3-L1 
cells at day 0 or day 2 as defined by having an intensity >3000 for at least one probe 
mapping to the gene on the Agilent microarray; (2) A lower mRNA expression level in 
day 2 cells in which miR-103 is ectopically expressed compared to control cells at day 2, 
using the cut-off FDR<0.05; (3) Predicted targets based on Targetscan v4.2. Conserved = 
conserved across human (H), mouse (M), rat (R), and dog (D).Context score is defined in 
the Targetscan database; a more negative score is associated with a more favorable 













Literature related to 
adipogenesis 
ACTG1 1 1 -0.23  
ACVR1 1 0 -0.13 pro-osteogenesis and pro-chondrogenesis 
ADAMTS1  1 0.00  
AFF1  2 -0.32  
AGRN  1 -0.06  
AIM2  1 -0.20  
AMMECR1L  1 0.04  
APLP2  1 -0.05  
ARID5B  1 -0.05  
ARNT 1 1 -0.43 anti-adipogenic  
ATP2B1 1 0 -0.06  





BACE1  2 -0.16  
BMF  1 -0.08  
CAMK2G 2 0 -0.08  
CAST  1 -0.19 anti-adipogenic 
CAV1  1 -0.51  
CC2D1B 1 2 -0.27  
CD47  1 -0.06  
CDK6 1 1 -0.20  
CDKN2B  1 -0.04  
CDSN  2 -0.24  
COL16A1  1 -0.09  
COL1A1  1 -0.21  
COL4A1  1 -0.16  
CSNK1G3 1 0 -0.20  
CSRP1  1 -0.11  
CTNNA1  1 -0.12  
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CX3CL1  2 -0.12  
DCTN4  1 -0.08  
DKFZP434B0335  1 -0.09  
DLGAP4 1 0 -0.10  
DNAJC10  1 -0.07  
EIF4B 1 1 -0.20  
ENAH  2 0.00  
EPHA4  1 -0.14  
EPN2  1 -0.10  
EPS15  1 -0.06  
ERBB2IP  2 -0.11  





FAM107A  1 -0.19  
FBN1  2 -0.43  
FBXO10 1 0 -0.34  
FNIP1  1 -0.20  
FZD1  2 -0.34 anti-adipogenic 
GALK2  1 -0.46  
GLCE  1 -0.06  
GLIS2  1 -0.23  
GOPC  2 -0.40  
GPR108  1 -0.09  
H6PD  2 -0.19  
HSD17B11  1 -0.11  
HYI  1 -0.09  
IGFBP3  1 -0.12  
IL10RB  1 -0.30  
IL1R1  1 -0.07  
JAK1  1 -0.03  
KITLG  1 -0.09  
KLF4 1 0 -0.14  
LIMA1  1 -0.11  
LIMD2  1 -0.05  
LITAF  1 -0.12  
LPP  4 -0.58  
LRP1 1 0 -0.06  
MAF1 1 0 -0.12  
MAP3K14  1 -0.05  
MAP4  1 -0.03  
MAP4K3  1 -0.09  
MAP4K4  2 -0.13  
MASP1  1 -0.09  
MATN2  1 -0.19  
MEIS2  1 -0.06  
MMP11  1 -0.09  
MNT  1 -0.02  
NDEL1 1 0 -0.34  
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NFAT5 1 0 -0.14  
NPEPPS  1 -0.27  
OGT 1 0 -0.19  
PDGFA  1 -0.06  
PDLIM2  1 -0.25  
PIK3R1 1 0 -0.21  
POLDIP2 1 0 -0.15  
POLM  1 -0.12  
PPP1R3C  1 -0.14  
PSD3  3 -0.07  
RAF1  1 0.00  
RAI16  2 -0.22  
REV3L  1 -0.18  





RPL22  1 -0.08  
RUNX1T1 1 0 -0.35 aka. ETO/MTG8,  anti-adipogenic 
SDC2  1 -0.07  
SDCBP  1 -0.38  
SENP6  1 -0.08  
SEPT11  1 -0.08  
SERINC3  1 -0.19  
SESN1  1 -0.06  
SLC25A17  1 -0.02  





SPTBN1  1 -0.07  
STARD3NL  1 -0.16  
SYT13  1 -0.24  
TEP1  1 -0.18  
THBS1  2 -0.16  
TIMP2  1 -0.10  
TMEM123  1 -0.09  
TMEM49  1 -0.18  
TNS1  1 -0.15  
TNS3  2 -0.22  
TPP1  1 -0.13  
TRAFD1  1 -0.14  
TSC22D3 1 0 -0.04 aka. Dsip1 
TSPAN9  3 -0.10  
UBE2B  1 -0.23  
UBE2H  1 -0.08  
UHRF2  1 -0.16  
VAMP5  1 -0.06  
VAT1  1 -0.16  
VGLL3  2 -0.09  
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WDFY2  2 -0.45  
WWC2  1 -0.10  
ZHX3 1 2 -0.19  
ZNF592  1 -0.29  
ZNRF1  1 -0.08  
ZYX 1 0 -0.10  
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Appendix 2. List of putative target genes of miR-143 at the early stage of 3T3-L1 
differentiation. These genes meet all of the following criteria: (1) Expressed in 3T3-L1 
cells at day 0 or day 2 as defined by having an intensity >3000 for at least one probe 
mapping to the gene on the Agilent microarray; (2) A lower mRNA expression level in 
day 2 cells in which miR-143 is ectopically expressed compared to control cells at day 2, 
using a the cut-off FDR<0.05; (3) Predicted targets based on Targetscan v4.2. Conserved 
= conserved across human (H), mouse (M), rat (R), and dog (D).Context score is defined 
in the Targetscan database; a more negative score is associated with a more favorable 













Literature related to 
adipogenesis 
ADAMTS1  3 -0.46  
ADAMTS5  1 -0.06  
AFF1  2 -0.35  
AGTR2  1 -0.10  
ANXA3 1 0 -0.20  
APBB2  1 -0.09  
ARNT  1 -0.25 anti-adipogenic  
ATP2B1  1 -0.05  
BACE1  3 -0.44  
CLIP3  1 -0.04  
CNN2  1 -0.24  
CRYZ  1 -0.32  
CXCL6  1 -0.28  
DPYSL3  1 0.01  
FLJ10357  1 -0.21  
GHR  1 -0.19  
IGF1  1 -0.08  
IL17RD  2 -0.13  
ISLR  1 -0.22  
KIAA0556  1 -0.16  
MAF 1 0 -0.21 downregulated during adipogenesis 
MAPK7 1 0 -0.29 aka. ERK5,  validated target of miR-143 
MEST  1 -0.17  
NFIB  1 -0.07  
OCRL  1 -0.14  
PALLD  1 -0.04  
PDGFRA 1 0 -0.07  
PDLIM2  1 -0.35  
PRSS23  1 -0.10  
PSD3 1 1 -0.26  
SIAE  1 -0.15  
SOCS3  1 -0.13  
SRA1  2 -0.39  
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SVEP1 1 0 -0.18  
SVIL  1 -0.21  
TIMP2  1 -0.12  
TMEM123  1 -0.05  
TMEM50A  1 -0.19  
TMSB10  1 -0.10  
TSC22D3 1 0 -0.26 aka. Dsip1 
TSPAN9  1 -0.06  
VGLL3  1 -0.27  
ZNF618 1 1 -0.14 aka. Zfp618 
 
 
 
 
 
